ClinicalTrials.gov
ClinicalTrials.gov Menu

Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00622674
Recruitment Status : Completed
First Posted : February 25, 2008
Last Update Posted : December 2, 2017
Sponsor:
Information provided by (Responsible Party):
Masonic Cancer Center, University of Minnesota

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2009
  Actual Study Completion Date : February 2010